Tumor markers in non-small cell lung cancer spine metastasis: an assessment of prognosis and overall survival.

IF 2.6 3区 医学 Q2 CLINICAL NEUROLOGY
European Spine Journal Pub Date : 2024-11-01 Epub Date: 2024-09-02 DOI:10.1007/s00586-024-08447-8
Brian Foresi, Aakash Shah, Seth Meade, Ajit Krishnaney
{"title":"Tumor markers in non-small cell lung cancer spine metastasis: an assessment of prognosis and overall survival.","authors":"Brian Foresi, Aakash Shah, Seth Meade, Ajit Krishnaney","doi":"10.1007/s00586-024-08447-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The identification of gene mutations in the modern medical workup of metastatic spine tumors has become more common but has not been highly utilized in surgical planning. Potential utility of these genetic markers as surrogates for cancer behavior in current prognosis scoring systems and overall survival (OS) remains underexplored in existing literature. This study seeks to investigate the association of frequently identified tumor markers, EGFR, ALK, and PD-L1, in metastatic non-small cell lung cancer (NSCLC) to the spine with Tokuhashi prognosis scoring and OS.</p><p><strong>Methods: </strong>Patients with NSCLC metastasis to spine were identified through chart review. EGFR, ALK, and PD-L1 wild type vs. mutant type were identified from targeted chemotherapy genetic testing. Multiple linear regression was performed to assess gene profile contributions to Tokuhashi score. Cox Proportional Hazards models were generated for each tumor marker to assess the relationship between each marker and OS.</p><p><strong>Results: </strong>A total of 119 patients with NSCLC spine metastasis were identified. We employed a multiple linear regression analysis to investigate the influence of EGFR, ALK, and PD-L1 genotypes on the Tokuhashi score, revealing statistically significant relationships overall (p = 0.002). Individual genotype contributions include EGFR as a non-significant contributor (p = 0.269) and ALK and PD-L1 as significant contributors (p = 0.037 and p = 0.001 respectively). Overall survival was not significantly associated with tumor marker profiles through Kaplan-Meier analysis (p = 0.46) or by multivariable analysis (p = 0.108).</p><p><strong>Conclusion: </strong>ALK and PD-L1 were significantly associated with Tokuhashi score while EGFR was not. Tumor markers alone were not predictive of OS. These findings indicate that genetic markers found in NSCLC metastases to the spine may demonstrate prognostic value. Therefore, employing standard tumor markers could enhance the identification of appropriate surgical candidates, although they demonstrate limited effectiveness in predicting overall survival.</p>","PeriodicalId":12323,"journal":{"name":"European Spine Journal","volume":" ","pages":"4346-4352"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Spine Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00586-024-08447-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The identification of gene mutations in the modern medical workup of metastatic spine tumors has become more common but has not been highly utilized in surgical planning. Potential utility of these genetic markers as surrogates for cancer behavior in current prognosis scoring systems and overall survival (OS) remains underexplored in existing literature. This study seeks to investigate the association of frequently identified tumor markers, EGFR, ALK, and PD-L1, in metastatic non-small cell lung cancer (NSCLC) to the spine with Tokuhashi prognosis scoring and OS.

Methods: Patients with NSCLC metastasis to spine were identified through chart review. EGFR, ALK, and PD-L1 wild type vs. mutant type were identified from targeted chemotherapy genetic testing. Multiple linear regression was performed to assess gene profile contributions to Tokuhashi score. Cox Proportional Hazards models were generated for each tumor marker to assess the relationship between each marker and OS.

Results: A total of 119 patients with NSCLC spine metastasis were identified. We employed a multiple linear regression analysis to investigate the influence of EGFR, ALK, and PD-L1 genotypes on the Tokuhashi score, revealing statistically significant relationships overall (p = 0.002). Individual genotype contributions include EGFR as a non-significant contributor (p = 0.269) and ALK and PD-L1 as significant contributors (p = 0.037 and p = 0.001 respectively). Overall survival was not significantly associated with tumor marker profiles through Kaplan-Meier analysis (p = 0.46) or by multivariable analysis (p = 0.108).

Conclusion: ALK and PD-L1 were significantly associated with Tokuhashi score while EGFR was not. Tumor markers alone were not predictive of OS. These findings indicate that genetic markers found in NSCLC metastases to the spine may demonstrate prognostic value. Therefore, employing standard tumor markers could enhance the identification of appropriate surgical candidates, although they demonstrate limited effectiveness in predicting overall survival.

Abstract Image

非小细胞肺癌脊柱转移的肿瘤标志物:预后和总生存期评估。
目的:在转移性脊柱肿瘤的现代医学检查中,基因突变的鉴定已变得越来越普遍,但在手术规划中的应用却不多。在现有文献中,这些基因标记物作为癌症行为替代物在当前预后评分系统和总生存期(OS)中的潜在作用仍未得到充分探讨。本研究旨在探讨脊柱转移性非小细胞肺癌(NSCLC)中常见肿瘤标记物(表皮生长因子受体、ALK和PD-L1)与德桥预后评分和OS的关系:方法:通过病历审查确定脊柱转移的非小细胞肺癌患者。通过靶向化疗基因检测确定 EGFR、ALK 和 PD-L1 野生型与突变型。进行多元线性回归以评估基因图谱对德桥评分的贡献。为每个肿瘤标记物建立了Cox比例危害模型,以评估每个标记物与OS之间的关系:结果:共发现 119 例 NSCLC 脊柱转移患者。我们采用多元线性回归分析来研究表皮生长因子受体、ALK 和 PD-L1 基因型对德桥评分的影响,结果显示总体上存在显著的统计学关系(p = 0.002)。单个基因型的贡献包括表皮生长因子受体(EGFR)为非显著贡献者(p = 0.269),ALK 和 PD-L1 为显著贡献者(分别为 p = 0.037 和 p = 0.001)。通过卡普兰-米尔分析(p = 0.46)或多变量分析(p = 0.108),总生存期与肿瘤标志物谱无明显关联:结论:ALK和PD-L1与德桥评分显著相关,而表皮生长因子受体与德桥评分无关。结论:ALK和PD-L1与德桥评分密切相关,而表皮生长因子受体(EGFR)与德桥评分无关。这些研究结果表明,在脊柱转移的 NSCLC 中发现的遗传标记物可能具有预后价值。因此,采用标准肿瘤标记物可以提高识别合适手术候选者的能力,尽管它们在预测总生存期方面的效果有限。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Spine Journal
European Spine Journal 医学-临床神经学
CiteScore
4.80
自引率
10.70%
发文量
373
审稿时长
2-4 weeks
期刊介绍: "European Spine Journal" is a publication founded in response to the increasing trend toward specialization in spinal surgery and spinal pathology in general. The Journal is devoted to all spine related disciplines, including functional and surgical anatomy of the spine, biomechanics and pathophysiology, diagnostic procedures, and neurology, surgery and outcomes. The aim of "European Spine Journal" is to support the further development of highly innovative spine treatments including but not restricted to surgery and to provide an integrated and balanced view of diagnostic, research and treatment procedures as well as outcomes that will enhance effective collaboration among specialists worldwide. The “European Spine Journal” also participates in education by means of videos, interactive meetings and the endorsement of educative efforts. Official publication of EUROSPINE, The Spine Society of Europe
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信